Zura Bio to Engage in Major November Conferences
Company Announcements

Zura Bio to Engage in Major November Conferences

The latest update is out from Zura Bio ( (ZURA) ).

Zura Bio Limited, a clinical-stage immunology company, is set to engage with investors at two major conferences in November 2024. The company, known for developing dual-pathway antibodies for autoimmune diseases, will participate in the Guggenheim Healthcare Innovation Conference in Boston and the Jefferies London Healthcare Conference. These events provide a platform for Zura Bio to showcase its promising therapeutic developments, including tibulizumab, crebankitug, and torudokimab, which are poised for Phase 2 trials.

For detailed information about ZURA stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyZura Bio initiated with an Outperform at Leerink
TheFlyZura Bio management to meet with Cantor Fitzgerald
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App